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Background: To determine relapse rates and associated factors among people who use drugs (PWUDs) attending
abstinence-oriented drug treatment clinics in Dhaka, Bangladesh.
Methods: A cohort of male and female PWUDs admitted to the 3-month drug detoxification-rehabilitation treatment
programmes of three non-governmental organisation-run drug treatment clinics in Dhaka, Bangladesh were
interviewed on admission and over the following 5 months, which included the first 2 months after discharge. The
study subjects comprised 150 male and 110 female PWUDs who had been taking opiates/opioids, cannabis or other
drugs (including sedatives) before admission, had provided informed consent and were aged ≥16 years. Interviews
were conducted using semi-structured questionnaires at four time points; on admission, at discharge and at 1 and 2
months after discharge. Relapse rates were assessed by the Kaplan–Meier method. Factors associated with relapse on
enrolment and after discharge were determined using the Cox proportional hazards regression model.
Results: A greater proportion of female than male subjects relapsed over the study period (71.9% versus 54.5%, p < 0.01).
For men, baseline factors associated with relapse were living with other PWUDs (relative hazard ratio [RHR] = 2.27),
living alone (RHR = 2.35) and not having sex with non-commercial partners (RHR = 2.27); whereas for women these
were previous history of drug treatment (RHR = 1.94), unstable housing (RHR = 2.44), higher earnings (RHR = 1.89),
preferring to smoke heroin (RHR = 3.62) and injecting buprenorphine/pethidine (RHR = 3.00). After discharge, relapse
for men was associated with unstable housing (RHR = 2.78), living alone (RHR = 3.69), higher earnings (RHR = 2.48) and
buying sex from sex workers (RHR = 2.29). Women’ relapses were associated with not having children to support
(RHR = 3.24) and selling sex (RHR = 2.56).
Conclusions: The relapse rate was higher for female PWUDs. For both male and female subjects the findings highlight
the importance of stable living conditions. Additionally, female PWUDs need gender-sensitive services and active
efforts to refer them for opioid substitution therapy, which should not be restricted only to people who inject drugs.
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In Bangladesh, there is a long history of illicit drug use,
particularly of cannabis and opiates [1]. The drugs com-
monly used have changed over time: heroin became very
popular in the early 1990s but, because it was in short
supply in the mid-1990s, other drugs were introduced
[1-3]. Pharmaceuticals, in particular buprenorphine, are
commonly injected, often with anti-histamines and di-
azepam. Injection of pethidine (meperidine) does occur,
but is less common. Heroin is rarely injected [3]; how-
ever, heroin smokers intermittently inject or sometimes
switch to injecting other drugs for various reasons [4,5].
At present multiple drugs are available and most people
who use drugs (PWUDs) are poly drug users [4]. As of
2009, it is estimated that there are 21,800–23,800 people
who inject drugs (PWIDs) in Bangladesh [6]. Available
information suggests that there are fewer female than male
PWUDs [4,7], and that they are mostly hidden and very
mobile. Most female PWUDs who have been accessed are
primarily non-injectors who prefer to smoke and inject
infrequently [4].
Harm reduction services for male PWIDs were initi-
ated in Dhaka in the late 1990s. These services include a
needle and syringe programme (NSP), treatment for
sexually transmitted infections (STIs), abscess manage-
ment, provision of rest and recreational facilities, HIV/
AIDS prevention education and distribution of male
condoms. The harm reduction services are operated pri-
marily through outreach workers and drop-in centres lo-
cated within the community. The NSP in Bangladesh
has been recognised as best practice by the Joint United
Nations Programme on HIV/AIDS [8]. These services,
which have now been expanded to cover different parts
of Bangladesh, reached approximately 60% of PWIDs in
2008 [9], when Bangladesh had the widest NSP coverage
in south Asia [10]. As of 2012, approximately 14,000
PWIDs are covered under the NSP of Bangladesh, in-
cluding 400–500 women (unpublished data).
Access to affordable and good-quality drug treatment is
a common demand emanating from PWIDs [11]. How-
ever, standardised drug detoxification and rehabilitation
services are not readily available in Bangladesh. As of
2008, eight government clinics were being operated by the
Department of Narcotics Control and Directorate of
Prisons of the Government of Bangladesh and 162 treatment
centres by private and non-governmental organisations
(NGOs) [9] Services provided through the non-government
sector are too expensive for the vast majority of PWUDs
in Bangladesh [4,10]. It is believed that the NGO-run
treatment programmes provide a wider range of services,
such as rehabilitation with health education, behavioural
change communication and life skills development, in
addition to detoxification. However, these clinics do not
follow any standard format and it is difficult to gauge thesuccess of their programmes. In response to the need
for good-quality and affordable treatment for PWUDs,
in August 2005, Family Health International (FHI)
established 10 drug treatment clinics in different areas
of Bangladesh, three of which are in Dhaka, the capital
city. These clinics have a standard 3-month programme
of detoxification and rehabilitation.
Although there is evidence that opioid substitution
therapy (OST) is both an effective harm reduction stra-
tegy and a form of drug treatment and does reduce re-
lapse rates [12], Bangladesh had no OST programmes
until 2010 [13], when one was approved as a pilot pro-
ject. Since this programme’s initiation in 2010, more
than 180 adult PWIDs have been enrolled, including
eight women who had failed abstinence-based treatment
at least twice (unpublished data). The pilot study had
positive outcomes in terms of reducing risk behaviours,
improving quality of life and improving physical and
mental status. Based on these results, the pilot study has
been scaled up to include 600 PWIDs over the next 3
years. However, it will still cover only a small proportion
of PWIDs and only those who inject; none of those who
use opioids but do not inject.
Relapse following drug treatment is common. It has
been reported globally even in countries with high rates of
completion of inpatient treatment: 33% in Nepal [14],
55.8% in China [15] and 60% in Switzerland [16] relapsed
into drug use between 1 month and 1 year after discharge
from treatment programmes. Multiple factors, such as
post-treatment incarceration, mental or other comorbid
disorders, craving for drugs and withdrawal symptoms, are
reportedly associated with relapse [17,18]. In Bangladesh
there are no reliable data on relapse following drug treat-
ment. Anecdotal evidence suggests that 60 – 90% of patients
eventually relapse.
To gain a better understanding of relapse rates and fac-
tors associated with relapse in Bangladesh, we conducted
a prospective study on male and female PWUDs in set-
tings where standardised, abstinence-oriented treatment
and rehabilitation services were being provided.
Methods
Sampling site and study population
Male and female PWUDs were enrolled on admission to
the three FHI-supported NGO drug treatment clinics in
Dhaka. These NGOs are Ashokti Punorbashon Nibash, the
Society for Community Health, Rehabilitation, Education
and Awareness, and Dhaka Ahsania Mission. These FHI-
supported residential and abstinence-oriented treatment
programmes are provided free of cost. The programme
consists of an initial 14-day detoxification followed by a
3-month rehabilitation programme at the same residential
setting. During detoxification, manifestations of withdrawal
are controlled by clonidine (alpha-2 adrenergic agonist),
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comitant medical conditions. During the 2-week de-
toxification period, PWUDs are not permitted to leave
the residential facilities but are allowed visitors once a
week and can use the telephone in the case of an emer-
gency. After completing the 2 weeks of detoxification,
PWUDs are permitted to return to their homes if they so
desire. The decision to participate in the residential re-
habilitation programme is voluntary and they can return to
do so whenever they are ready. During the 3 months of
residential rehabilitation, PWUDs are allowed to visit their
homes in their villages or towns only as a rehabilitation
programme activity to develop their coping skills.
While at the treatment centre, PWUDs receive regu-
lar health check-ups, clinical care and counselling
(with or without family members). Towards the end of
the programme, they are provided life skills and voca-
tional training. Psychotherapeutic support, including
management of craving and peer pressure, anger con-
trol, meditation and prayer, is provided by counsellors.
PWUDs are also given basic education on sexual health
including HIV/AIDS and STI prevention and drug-
related harm. Physicians are available 6 days a week to
respond to manifestations of drug withdrawal or un-
complicated psychiatric problems. On completion of
the 3-month programme, the PWUDs are discharged
and can return to their communities. Table 1 shows
the daily schedule of the rehabilitation programme at
the three NGO-run clinics.
In this study, male and female PWUDs who were ≥16
years of age, fulfilled the clinical entry criteria set by
the FHI and the clinics and provided informed consent
were enrolled at the time of their admission to these
clinics. The clinical criteria for admission were readi-
ness for treatment and absence of severe comorbidities,
including diabetes mellitus, liver disorders, epilepsy,
psychiatric disorders and cardiac or respiratory prob-
lems. The reason for exclusion of PWUDs with psychi-
atric disorders was that no psychiatrists were available
at the clinics. However, if PWUDs were diagnosed with
a psychiatric disorder after admission, they were re-
ferred to psychiatrists at other institutions. In addition,
pregnant women were not admitted because the clinics
did not have the facilities and staff for adequate hand-
ling of obstetric emergencies.
In this study, the PWUDs included both those who
injected (i.e. PWIDs) and those who smoked heroin.
PWIDs were defined as those for whom the main route of
drug administration was injection and who had injected at
least once in the past 6 months. Heroin smokers were de-
fined as those whose drug of choice was heroin, whose
main route of drug administration was inhalation (smo-
king, chasing or snorting), and who had not injected drugs
more than twice in the last 6 months.Study design
All enrolled PWUDs had one-to-one interviews using
semi-structured questionnaires at four time points over
a period of 5 months to determine risk behaviours. The
interviews were conducted by trained male and female
interviewers on admission to and discharge from the
clinics and twice in the community, 1 and 2 months
after discharge. Those who dropped out of the treatment
programme were interviewed at the point of dropout
(before leaving the clinic) where possible, or in the com-
munity after dropout as soon as they had been located.
Prior to enrolment written informed consent was
obtained from all PWUDs. The study was approved by
the Research and Ethical Review Committees of the
International Centre for Diarrhoeal Diseases Research,
Bangladesh.
Determination of characteristics of enrolled PWUDs, risk
behaviour and relapse
The semi-structured questionnaire was designed to ascer-
tain relevant socio-demographic characteristics, history of
drug use, HIV risk behaviours related to drugs and unsafe
sex and reasons for relapse following treatment.
Relevant socio-demographic characteristics of PWUDs
included where they lived, who they lived with and their
income. Where they lived was classified according to the
UN-Habitat definitions [19] as shown below:
 House: a durable structure, independently built and
with access to adequate sanitation such as private
toilets and safe water.
 Working place: includes shops, offices, clubs or
wherever the person works that provides adequate
shelter with access to toilets.
 Street: an open space with minimal shelter such as
under awnings, in abandoned buildings, verandas
and bus/train terminals.
 Slum: a household shared by a group of individuals in an
urban area characterised by substandard, non-durable
housing and shared basic sanitation facilities.
These categories were regrouped into unstable housing
(unsheltered locations categorised above under “street”)
and stable housing (all other locations, namely house,
working place and slum).
For drug use characteristics and injection-related
risk behaviours, questions were asked about preferred
choice of drugs, route(s) of administration and injec-
tion practices (whether interviewees had borrowed or lent
used needles/syringes; number of sharing partners in the
last sharing episode and frequency of sharing). For sexual
risk behaviours, questions were asked about history of sex
with non-commercial and commercial sex partners, con-
dom use during last sex and frequency of condom use.
Table 1 Daily schedule of NGO-run drug detoxification-rehabilitation programme in Dhaka, Bangladesh
Detoxification
period: (14 days)
• Before and immediately after admission, the clinic center rules and regulations, service details are informed to the
client.
• The program schedule is flexible for the client as they struggle with withdrawal symptoms and are not fit enough
physically and mentally.
• Close supervision by medical professionals is ensured for the client during this period based on the treatment protocol that
covers pharmacological withdrawal control, monitoring and precautions, other symptomatic medications applicable at clinics.
• Motivational sessions are offered to the client after 7 days to learn benefits of drug free lives, risk of drug use, HIV/STI,
Tuberculosis.
• After two weeks of detoxification period, the clients are fully involved as shown in the schedule below of the rehabilitation
program:
Time Session/activities Psychosocial and clinical course content
6:15–6:45 Wake up and morning prayer Prayer (within the group)
6:45–7:00 Exercise Freehand exercise and YOGA
7:00–7:45 Housework Occupational therapy
7:45–8:30 Wash/refreshing & group work
8:30–9:15 Breakfast & medicine
9:15–9:45 Quiet time/relaxation & pre meeting Relaxation and meditation
9:45–10:30 Morning meeting/self evaluation Therapeutic community’s morning meeting for community life/individual weekly
evaluation
10:30–10:45 Free or personal time/(bathroom,
wash)
Personal hygiene and care
10:45–11:30 Morning session Addiction, anger management, post acute withdrawal management, building
self-esteem, values, HIV & STI, communication
11:30–12:00 Tea break
12:00-12-30 Occupational therapy/crafts work/
routine health check-up
Development of habit for daily routine/health check-up
12:30–1:15 Wash/bath time Personal hygiene and care
1:15–1:45 Prayer time & Talim (preaching) Religious practice
1:45–2:45 Lunch & medicine, rest
2:45–3:30 Evening session Planning, relapse prevention, group therapy, psycho therapy, resentment, basics of
behavior change
3:30–3:45 Routine work/house work Occupational therapy
3:45–4:00 Prayer time Religious practice
4:00–4:15 Tea break
4:15–5:15 Sports & recreation Outdoor games. summer- football, volleyball. winter- cricket, badminton
5:15–5:30 Prayer time
5:360–6:15 Quite time
6:15–7:00 Narcotics anonymous meeting
(sharing meeting)
Verbalize and ventilate emotion, feeling, experience , etc.
7:00–8:00 Group meeting Community meeting
8:00–8:30 Prayer time
8:30–9:00 Dinner & medicine
9:00–9:50 Free time/recreation/watching TV
9:50–10:00 Bed preparation & self-cleaning
10:00–10:45 Night sharing Sharing and moral inventory
10:45 Bed time and lights off
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drugs were used after discharge or dropout from the
treatment programmes. This was determined by the re-
sponse to the question “When did you first take drugs
after discharge (or dropout)?”, which was asked when
PWUDs were interviewed in the community 1 and 2
months after discharge. The single open-ended question
“What was your reason for starting drug use again after
discharge?” was asked to determine the reasons for re-
lapse and the responses allocated to one of the following
five categories:
 Peer influence.
 Family-related problems such as loneliness, poverty,
family disputes and abuse by family members.
 Personal problems such as lack of job or money,
concern about own pregnancy, legal case, problems
with lover/girlfriend or boyfriend, dropping out of
school or work and abuse by members of their local
communities.
 Drug craving, including withdrawal symptoms.
 To enhance sexual performance.
Additionally, the following questions were asked to de-
termine whether PWUDs perceived any changes in their
drug use pattern following drug treatment and what those
changes were: “Do you think your current drug use habit
is different from that before your admission?” and “What
is different from your previous drug use pattern?”
Statistical analyses
Enrolled PWUDs were divided into two groups, male
and female PWUDs. Data were entered using Epi-Info
(Version 3, Centres for Diseases Control and Prevention,
Georgia, USA) and analysed using the Statistical Package
for Social Sciences (SPSS) Version 15 (IBM Corporation,
New York, USA). To determine whether there were dif-
ferences between male and female PWUDs in baseline
characteristics assessed on enrolment, these characteris-
tics were compared between male and female PWUDs
using the χ2 test for categorical data and the Mann–
Whitney U test for nonparametric data. The Kaplan–
Meier method was used to construct curves of time to
relapse and determine median times to relapse for male
and female PWUDs who completed the detoxification-
rehabilitation programme and were followed up after
discharge for at least 1 month. The log-rank test was
used to compare times to relapse between male and fe-
male PWUDs [20].
Relapse may be associated with characteristics that
PWUDs had before admission to the treatment pro-
gramme (determined during admission interviews) or
with factors that influence them after they return
to their communities (determined through interviewsconducted in the community after discharge). There-
fore, data from two time points, namely on admission
and after discharge, were subjected to bivariate analysis
using the univariate Cox proportional hazards model to
determine factors associated with relapse separately for
male and female PWUDs [21]. Variables found to be
significant at the 5% level by bivariate analysis were
subjected to a multivariate backward stepwise Cox pro-
portional hazards regression to determine the net effect
of the factors associated with relapse. The effects of risk
factors on relapse are expressed as relative hazard ratios
(RHR) with their corresponding 95% confidence intervals
(CI) and p-values. Covariates with p-values of ≤ 0.05
were considered to be significant.
Results
Response rate
Figure 1 is a flow diagram showing numbers of subjects at
various stages of the study. In all, 150 male and 110 female
PWUDs were enrolled from January 2008 to February
2009 and 133 men and 95 women completed the 3-month
treatment programme. Among those who completed
treatment, 120 men and 83 women also completed the
study. Of those who did not complete the study; five
male and six female subjects were followed up for only
1 month and eight men and six women could not even
be reached at 1 month after discharge. The reasons for
loss to follow-up were not having supplied a valid ad-
dress (10 men and 10 women), death (one woman)
and imprisonment after discharge (one woman and
three men).
The reasons for dropping out of the treatment pro-
gramme were varied and included family reasons (one
man and three women), health issues (two men and two
women developed chicken pox), pregnancy identified after
admission (two women) and inability to adjust to the
treatment programme (three men and three women).
Thus, valid data for analyses related to relapse were
available from 123 male and 89 female subjects.
Baseline characteristics of drug users (on admission
to clinics)
Table 2 shows the baseline characteristics of male and
female PWUDs during the 6 months prior to admission.
Most PWUDs enrolled in this study provided a previ-
ous history of attending drug treatment programmes but
this was more common in female subjects (men: 54%,
women: 67.3%, p < 0.05). The women were younger than
the men (p < 0.01), more were currently married or living
with a partner (p < 0.05) and their median monthly earn-
ing was 1.6 times greater than that of the men (p < 0.01).
The locations where they usually lived differed signifi-
cantly between men and women; more women lived in
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interview only and 








*Study completed: those who completed all four interviews over the study period, i.e. on admission, at discharge/dropout, at 1 month and 2 months after
discharge/dropout.
**Study dropout: those who did not complete all interviews over the study period.
Figure 1 Flow diagram showing number of subjects at various stages of the study. Two flow diagrams to describe numbers of male
(N=150) and female (N=110) study participants from respetive enrollment at admission until the study completion at the two months follow-up
interview after discharge.
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More than 85% of the enrolled drug users had no child-
care needs.
The majority of the women preferred to inhale her-
oin, whereas the men preferred to inject pharmaceuti-
cals; the same trend was seen in preferred route of
drug administration. Among PWIDs (144 men and 26
women), there were no differences in the proportions
of men and women who said they had shared needles/
syringes during their most recent injection. However,
men were more likely to share other injection para-
phernalia (91.7% for men versus 42.3% for women,
p < 0.01).
Regarding sexual behaviour, more female PWUDs
reported engaging in commercial sex: 30.7% of men
bought sex from sex workers, whereas almost half the
women sold sex in exchange for drugs or money (p < 0.01).
Six women, including three who sold sex, also reported
buying sex. In addition, group sex was more commonly
reported by women (p < 0.01). More men than womenreported consistent use of condoms during commercial
sex (p = 0.04). More than 45% of both male and female
subjects reported having sex under the influence of
drugs; this did not differ between the two groups.
Men more commonly reported having ever been im-
prisoned or selling blood than did women (p < 0.01 for
both factors).
Relapse among drug users who completed the 3-month
treatment programme
Relapse rates and median time to relapse were calculated
for the 123 male and 89 female PWUDs who completed
treatment and for whom date of relapse was available.
Of these subjects, 118 men and 83 women had com-
pleted all interviews throughout the study, whereas five
men and six women could not be located for the second
post-discharge interview (Figure 1).
Higher relapse rates were recorded for women than
for men over the 2-month post-discharge observation
period (71.9% versus 54.5%, p < 0.01) (Figure 2). Median
Table 2 Comparison of baseline characteristics of PWUDs (on admission to clinics)
Characteristics Male PWUDs Female PWUDs p
(N = 150, unless
otherwise stated)
(N = 110, unless
otherwise stated)
Socio-demographic factors
Had previous experience of drug treatment programmes 54.0 (81) 67.3 (74) 0.03
Age in years
Mean (SD)* 32.6 (±7.0) 26.8 (±6.4)
Median (IQR)▲ 32.0 (27.0, 36.3) 25.0 (22.0, 30.0) <0.01
Level of education, % (n)
Less than 1 year 10.7 (16) 19.1 (21) 0.05
1–5 years 64.0 (96) 61.8 (68) NS
>5 years 25.3 (38) 19.1 (21) NS
Marital status, % (n)
Married / living with sex partner 31.3 (47) 43.8 (49) 0.03
Unmarried 36.0 (54) 10.9 (12) <0.01
Divorced/separated/widower/widow 32.7 (59) 44.5 (49) 0.05
Income level (monthly average in BDT△)
Mean (SD)* 6144 (±3997) 11397 (±8750)
Median (IQR) ▲ 5000 (3500, 7000) 7900 (5000, 15250) <0.01
% more than Mean 33.7 38.2
Locations where they live, % (n)
House 48.7 (73) 30.9 (34) <0.01
Working place (shop, office, club) 4.0 (6) 4.5 (5) NS
Street§ 42.0 (63) 20.9 (23) <0.01
Slum 5.3 (8) 43.6 (48) <0.01
Person(s) with whom they usually live, % (n)
Family member, relative 40.7 (61) 34.5 (38) NS
Spouse, sex partner 14.0 (21) 16.3 (18) NS
Non-PWUD friend, colleague 2.6 (4) 6.3 (7) NS
PWUD friend, drug dealer 26.7 (40) 29.1 (32) NS
Alone 16.0 (24) 13.6 (15) NS
Have children to support, % (n) 10.7 (16) 13.6 (15) NS
History of drug misuse (in the last six months before admission)
Drug primarily preferred for consumption, % (n)
Cannabis, sleeping pills, codeine containing cough syrup, alcohol 1.3 (2) 13.6 (15) <0.01
Heroin 16.7 (25) 72.8 (80) <0.01
Buprenorphine, pethidine 82.0 (123) 13.6 (15) <0.01
Main route of drug administration, % (n)
Orally 0.0 (0) 3.6 (4) 0.03
Inhaling (smoking, snorting, chasing) 13.3 (20) 82.7 (91) <0.01
Injection 86.7 (130) 13.6 (15) <0.01
Duration (years) of injecting drugs (among those who injected in the last six months) N = 144 N = 26
Mean (SD)* 5.9 (±4.4) 4.1 (±4.7)
Median (IQR) ▲ 5.0 (3.0, 8.0) 2.5 (1.0, 6.25) 0.01
% more than mean 34.0 (60) 35.6 (9)
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Table 2 Comparison of baseline characteristics of PWUDs (on admission to clinics) (Continued)
Shared used needle/syringe during last injection (among those who injected
in the last six months), % (n)
N = 144 N = 26
54.2 (78) 34.6 (9) NS
Shared injection paraphernalia during last injection (among those who injected
in the last six months), % (n)
N = 144 N = 26
91.7 (132) 42.3 (11) <0.01
Sexual behaviour (in the last six months before admission)
Had any type of sex, % (n) 58.0 (87) 70.0 (77) 0.05
Bought sex from sex worker, % (n) 30.7 (46) 5.5 (6) <0.01
Sold sex in exchange of money or drugs, % (n) 0 49.1 (54) <0.01
Frequency of using condoms during sex with commercial sex partner
(among those who bought or sold sex), % (n)
N = 46 N = 54
Always 63.0 (29) 42.6 (23) 0.04
Sometimes 13.1 (6) 40.7 (22) <0.01
Never 23.9 (11) 9 (16.7) NS
Had sex with non-commercial partner, % (n) 35.3 (53) 45.4 (50) NS
Frequency of using condom during sex with non-commercial partner
(among those who had sex with non-commercial partner), % (n)
N = 53 N = 50
Always 20.8 (11) 16.0 (8) NS
Sometimes 22.6 (12) 18.0 (9) NS
Never 56.6 (30) 66.0 (33) NS
Had group sex, % (n) 2.7 (4) 19.1 (21) <0.01
Had sex just after taking drugs, % (n) 45.3 (68) 50.9 (56) NS
Other risk behaviours (before admission)
Ever been imprisoned, % (n) 60.7 (91) 41.8 (46) <0.01
Ever sold blood, % (n) 27.3 (41) 13.6 (15) 0.01
*SD Standard Deviation, ▲IQR inter-quartile range, NS not significant (p>0.05).
△1 USD is equivalent to 75.88 BDT as of October 2011.


































































After 1 month(31 
days)
Censored at 2 months 
(62 days)
Figure 2 Relapse among PWUD who completed the three-month treatment programme. Survival curve to compare cumulative survival
ratio of male and female drug users who relapsed within two months (62 days) after discharge from a three-month detoxification-rehabilitation
programme at three NGO-run clinics.
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women. Most of the relapses occurred during the first
30 days after discharge in both sexes.
Factors associated with relapse in male and
female PWUDs
The baseline covariates associated with relapse differed be-
tween male and female PWUDs (Table 3). Men were more
likely to relapse if they were living with other PWUD
friends or drug dealers (RHR = 2.27, p < 0.01), living
alone (RHR = 2.35, p = 0.02) or not having sex with
non-commercial partners (RHR = 2.27, p = 0.01).
Women were more likely to relapse if they had pre-
viously attended other drug treatment programmes
(RHR = 1.94, p = 0.03), lived in unstable housing
(RHR = 2.44, p = 0.01), had incomes higher than the
monthly average (RHR = 1.89, p = 0.02) or preferred
to smoke heroin (RHR = 3.62, p = 0.01) or inject
buprenorphine or pethidine (RHR = 3.00, p = 0.05) rather
than take cannabis, sleeping pills, codeine containing
cough syrup or alcohol.
At post-discharge follow-up (Table 4), relapse of men was




Had previously undergone drug treatment
Location where they live
Stable housing§
Unstable housing†
Person(s) with whom they usually live
Family member, relative
Spouse, sex partner −0.10
Non-PWUD friend, colleague 1.06
PWUD friend, drug dealer 0.82
Alone 0.85
Income level
More than the monthly average ‡
History of drug misuse (in the last six months before admission)
Type of drug used as the first choice
Cannabis, sleeping pills, codeine containing cough syrup, alcohol
Heroin
Buprenorphine, Pethidine
Sexual behaviour (in the last six months before admission)
Not had sex with non-commercial partner 0.82
*Only the covariates with significance of at least a 5% level for association with rela
§Stable housing = house, working place, shop, office, club.
†Unstable housing = street, abandoned place, park, roof-top, veranda, bus/train ter
‡Monthly average incomes are BDT 6144 for male, and BDT 11397 for female (1USD
B: Net effect of independent variable. RHR relative hazards risk, CI confidence intervp = 0.04), living alone (RHR = 3.69, p = 0.02), having higher
incomes than the mean monthly average (RHR = 2.48, p =
0.01) and buying sex from sex workers (RHR = 2.29, p =
0.01). Women’s relapses were associated with not having
children to support (RHR = 3.24, p < 0.01) and selling sex
in exchange for money or drugs (RHR = 2.56, p < 0.01).
Perceived reasons for relapse and changes in drug use
patterns after drug treatment
The two most common reasons for relapse were peer in-
fluence and family-related stress (Table 5). There were
no differences between men and women in this regard.
It is notable that, although women had a higher relapse
rate (Figure 2), more women than men reported changes
in their drug taking behaviour in that they had decreased
the frequency or amount of drug consumed (p < 0.05).
Discussion
This study documents for the first time the characteris-
tics of relapse following abstinence-oriented drug treat-
ment among PWUD in Bangladesh. The data clearly
show that relapse is common, occurring within 1 month
of discharge from the treatment facility in most cases.ith relapse of male and female PWUDs
Male PWUDs (N = 123) Female PWUDs (N = 89)
p Adjusted RHR (95% CI) B p Adjusted RHR (95% CI)
0.66 0.03 1.94 (1.08−3.49)
1.00 (Ref.)






0.64 0.02 1.89 (1.13−3.17)
1.00 (Ref.)
1.29 0.01 3.62 (1.39−9.46)
1.10 0.05 3.00 (1.02−8.81)
0.01 2.27 (1.19−4.33)
pse were analysed by backward stepwise Cox multivariate analyses.
minal.
is equivalent to 76.20 BDT as of 31 October 2011).
al.
Table 4 Follow-up covariates* (1 month after discharge) associated with relapse of male and female PWUDs
Covariate Male PWUDs (N = 123) Female PWUDs (N = 89)
Category B p Adjusted RHR (95% CI) B p Adjusted RHR (95% CI)
Socio-demographic factors
Location where they live
Stable housing§ 1.0 (Ref.) 1.0 (Ref.)
Unstable housing† 1.02 0.04 2.78 (1.05−7.35) −0.68 0.06 0.51 (0.25−1.02)
Person(s) with whom they usually live
Family member, relative 1.0 (Ref.)
Spouse, sex partner −0.25 0.56 0.78 (0.34−1.79)
Non-PWUD friend, colleague −0.83 0.05 0.44 (0.19−0.99)
PWUD friend, drug dealer 0.06 0.93 1.06 (0.25−3.95)
Alone 1.31 0.02 3.69 (1.29−10.53
Income level
More than monthly average ‡ 0.91 0.01 2.48 (1.22−5.02)
Not having children to support 1.18 <0.01 3.24 (1.38−7.64)
Sexual behaviour (in the past 1 month)
Bought sex from sex workers 0.83 0.01 2.29 (1.25−4.20)
Sold sex in exchange of money or drugs 0.94 <0.01 2.56 (1.52−4.29)
*Only the covariates with significance of at least a 5% level for association with relapse by backward stepwise Cox multivariate analyses.
§Stable housing = house, working place, shop, office, club.
†Unstable housing = street, abandoned place, park, roof-top, veranda, bus/train terminal.
‡Monthly average incomes are BDT 6144 for male, and BDT 11397 for female (1USD is equivalent to 76.20 BDT as of 31 October 2011).
B: Net effect of independent variables. RHR relative hazards risk, CI confidence interval.
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http://www.harmreductionjournal.com/content/10/1/14The relapse rates documented in this study are compar-
able to those from developed countries, which show 60%
or more relapse amongst heroin users [16,22]. However,
the relapse rates recorded here occurred following treat-
ment in clinics by a standardised, structured approach thatTable 5 Perceived reasons for relapse and changes in drug us
detoxification-rehabilitation programme
Characteristics M
Reason to relapse, % (n)
Peer influence (previous PWUD friends, sexual partner’s drug use)
Family-related problem (no peace, poverty in family)
Personal problems
Drug craving, withdrawal symptoms (including restlessness,
sleeping disturbance)
To enhance sexual power
Changes perceived in current drug use pattern, % (n)
Major difference from previous drug use pattern (among those
who perceived changes), %(n)
Decreased frequency or amount
Increased frequency or amount
Type of drugs preferred
Not specified
*NS not significant (p>0.05).combines detoxification, rehabilitation and training on dif-
ferent behavioural aspects in a 3-month programme. It is
not known whether these results can be generalized to
PWUDs who undergo treatment in other clinics and
programmes in Bangladesh. Furthermore, although it ise patterns 2 months after discharge from a 3-month drug
ale PWUDs N = 67, unless
otherwise stated
Female PWUDs N = 64, unless
otherwise stated
P
(N = 67) (N = 64) NS*
32.8 (22) 45.3 (29) NS
35.8 (24) 35.9 (23) NS
19.4 (13) 14.1 (9) NS
9.0 (6) 4.7 (3) NS
3.0 (2) -
(N = 67) (N = 64) 0.02
59.7 (40) 79.7 (51)
(N = 40) (N = 51)
55.0 (22) 62.7 (32) 0.01
10.0 (4) 15.7 (8) NS
35.0 (14) 13.7 (7) NS
- 7.8 (4) NS
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http://www.harmreductionjournal.com/content/10/1/14likely that the numbers of PWUDs who relapsed would
have increased if they had been followed up for longer
than 2 months after discharge, it is not clear whether
the rate of relapse would have increased over time.
Other studies have shown that the initial few post-
treatment months are the most vulnerable period for
relapse [16,22,23].
This study also demonstrates that relapse is more com-
mon among female PWUDs. Moreover, most women who
were enrolled in this study had previously undergone
treatment and therefore already had a history of relapse.
We found that these women who had previously under-
gone treatment had almost twice the risk of relapsing
again compared with those who had not. From this study
it was not possible to gauge the reasons for repeated drug
treatment failures. However, according to anecdotes of
service providers, female PWUDs who sell sex seek treat-
ment repeatedly because their ability to attract clients of
commercial sex deteriorates with prolonged drug use:
once treated, they are again attractive to clients. The find-
ing that female PWUDs who sold sex after discharge were
2.5 times more likely to relapse than those who did not
may support this possibility, but alternatively could reflect
the need to earn money for drugs by selling sex. Injection
of pharmaceuticals was less common among female than
male PWUDs, most women preferring to smoke heroin;
this has been shown in previous studies [1,4,7]. It is be-
lieved that relapse is generally more common among
those who use heroin than among those who use other
drugs [22], which could explain why the women enrolled
in this study had higher relapse rates than the men.
For both male and female subjects, where they lived
and who they lived with before admission to the clinic
correlated with relapse rates: for men, the relevant fac-
tors were living with peer groups of PWUDs and alone
and for women unstable living conditions. These struc-
tural factors indicate enhanced vulnerability of subjects
who lack family support and are lonely, isolated or sup-
ported only by other PWUDs, factors that may serve to
reinforce drug-taking behaviours. Analysis of post-
discharge factors produced a similar finding in that men
returning to an environment of living alone and in un-
stable housing were more likely to relapse. The import-
ance of estrangement from families is further supported
by the findings that for a large proportion of PWUDs,
the primary reason for relapse was pressure from PWUD
friends or sexual partners. Several studies have shown
that poor, unstable living conditions promote risky be-
haviours with regard to drug use because they poten-
tially expose PWUDs to high rates of violence, sexual
abuse and other vulnerabilities [24-26].
In the OST pilot project implemented in Bangladesh
in 2010, of the 180 PWIDs enrolled only eight were fe-
male; four of them dropped out. The reasons fordropping out were that their male injecting partners had
dropped out and the distance between the OST clinic
and where they lived (unpublished data). Although it is
difficult to generalise from these small numbers, the
contexts appear to be similar to those of female PWUDs
who drop out of or relapse from drug treatment
programmes. The small numbers of women enrolled in
the OST pilot study are mainly because it accepts only
injectors: most female PWUDs are primarily smokers.
The finding that men who were not having non-
commercial sex before admission are at enhanced risk of
relapse reinforces the importance of a supportive family
and happy conjugal life. For women, the enhanced risk of
relapse associated with not having children to support may
also be a reflection of not having a family: both the emo-
tional support and responsibilities associated with having a
family can work as deterrents to living a chaotic life
[25,27]. Although the NGO-run treatment programmes
have provisions for family counselling, it is not always pos-
sible to provide this. Moreover, childcare facilities or
pregnancy-related services are completely absent from
these NGO-run programmes. Conversely, PWIDs attend-
ing the OST pilot for at least 1 year showed remarkable
improvement in their family life and overall quality of life
(unpublished data).
In addition to assessing differences in factors associated
with relapse among male and female PWUDs, this study
highlights other differences between men and women who
access drug treatment. Many female PWUDs enrolled in
this study sold sex, had multiple sex partners, often con-
comitantly, and used condoms less frequently with their
commercial partners than did the male PWUDs. Such risk
behaviours have been documented before from Bangladesh
[7,9]. All published data from these studies confirm that fe-
male PWUDs require harm reduction services both in re-
gard to drugs and to promoting safe sex. The vulnerability
of male PWUDs was also high as shown by the high rates
of imprisonment and the known correlation between im-
prisonment and HIV infection [28-30]. Moreover, to earn
money, more male than female PWUDs sold blood. This is
of particular concern because a large proportion of the
men enrolled in our study were injectors and the national
sero-surveillance data of 2007 showed that 54% of male
PWIDs in Dhaka had antibodies to hepatitis C [11,31].
This study was conducted prior to the introduction of
the OST pilot programme in Bangladesh. Experience and
information gained from the OST pilot has led to the
Ministries of Health and Home of the Government of
Bangladesh to acknowledge that OST using methadone
is effective not only in terms of harm reduction but as
treatment. Repeated attempts at drug treatment and high
relapse rates make both male PWIDs and female PWUDs
ideal candidates for OST. The availability of OST for
those who use opioids but do not necessarily inject
Maehira et al. Harm Reduction Journal 2013, 10:14 Page 12 of 13
http://www.harmreductionjournal.com/content/10/1/14would no doubt improve the situation given the evidence
available from other countries such as the Netherlands
[12]. Thus, it is important to develop linkages between
the drug treatment and OST clinics in the future.
Conclusions
Relapse after frequent (standardised) abstinence-oriented
inpatient treatment in a Bangladesh sample, with opioid
dependence and without OST, is extremely high. There
are gender differences and social factors play a role in
relapse. Drug dependence is recognised to be a multi-
factorial health disorder that often follows the course of
a relapsing and remitting chronic disease [32]. To en-
hance the coverage and maximise the outcomes of drug
treatment strategies in Bangladesh, a comprehensive ap-
proach with psychosocially assisted pharmacological
treatment should become available and accessible for
PWUDs [33,34]. Especially for poor and marginalized
PWUDs, this would address diverse issues, in a gender-
sensitive manner.
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